Efforts to develop new antitumor agents are now directed towards multitarget therapies that are believed to have high potency and low tendency to resistance compared to conventional drugs. Herein, we highlighted the synthesis and antitumor activity of five series of phthalazine-based compounds featuring a variety of bioactive chemical fragments at position 1 of the phthalazine nucleus. The antitumor activity of the target compounds was performed against fourteen cancer cell lines where all compounds were active in the nanomolar level. In addition, the mechanism of action of the target compounds was investigated through an enzymatic inhibitory assay against VEGFR-2 and EGFR kinases, revealing potent and preferential activity toward VEGFR-2. Binding mode of the most active compounds was studied using docking experiment.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.ejmech.2016.07.049 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Targeting RTKs/nRTKs as promising therapeutic strategies for the treatment of triple-negative breast cancer: evidence from clinical trials.
Mil Med Res
December 2024
Cancer Biology Laboratory, Department of Biosciences and Bioengineering, Indian Institute of Technology Guwahati (IITG), Guwahati, Assam, 781039, India.
Article Synopsis
- - The prognosis for triple-negative breast cancer (TNBC) is challenging due to its heterogeneity and a lack of effective targeted therapies, prompting research into tyrosine kinases (TKs) as crucial contributors to tumor behavior and potential treatment targets.
- - Recent advancements in precision medicine have led to the exploration of various TK-targeted therapies, including monoclonal antibodies and small molecule inhibitors, that aim to combat TNBC by targeting key proteins like EGFR and VEGF.
- - The review emphasizes the importance of molecular characterization of TNBCs to maximize the effectiveness of TK-targeted therapies, indicating that treatment outcomes can significantly vary based on patient diversity.
New pyrano-pyridine conjugates as potential anticancer agents: design, synthesis and computational studies.
Future Med Chem
November 2024
Department of Pharmaceutical Medicinal Chemistry and Drug Design, Faculty of Pharmacy (Girls), Al-Azhar University, Cairo, Egypt.
Article Synopsis
- * The new compounds were tested in the lab against various cancer cell lines and showed promising results, particularly compounds 8a and 8b, which had higher anticancer activity compared to the standard drug, erlotinib.
- * Compound 8a also showed effective inhibition of specific cancer-related proteins (EGFR and VEGFR-2), and additional computational studies provided insights into the compounds’ properties and how they might behave in the body.
New series of 4,6-diaryl pyrimidines: facile synthesis and antiproliferative activity as dual EGFR/VEGFR-2 inhibitors.
Front Chem
November 2024
Pharmaceutical Organic Chemistry Department, Faculty of Pharmacy, Assiut University, Assiut, Egypt.
Article Synopsis
- - A new series of 4,6-diaryl-pyrimidines was created as potential cancer treatments that specifically target EGFR and VEGFR-2 pathways.
- - Among the synthesized compounds, two were found to be particularly effective, showing GI values of 22 and 24 nM, while also acting as dual inhibitors and promoting apoptosis in cancer cells.
- - The promising results included lower cell migration rates and superior docking scores compared to established drugs, suggesting these new compounds have great potential for further development in cancer therapy.
Harnessing potential COX-2 engagement for boosting anticancer activity of substituted 2-mercapto-4(3H)-quinazolinones with promising EGFR/VEGFR-2 inhibitory activities.
Bioorg Chem
December 2024
Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, P. O. Box 2457, Riyadh 11451, Saudi Arabia.
We designed and synthesized new quinazolinone-tethered phenyl thiourea/thiadiazole derivatives 4-26. Based on their structural characteristics, these compounds were proposed to have a multi-target mode of action for their anticancer activities. Using the MTT assay method, antiproliferative effects were assessed against three human cancer cell lines (HEPG-2, MCF-7, and HCT-116).
View Article and Find Full Text PDFRadiation-induced nanogel engineering based on pectin for pH-responsive rutin delivery for cancer treatment.
Naunyn Schmiedebergs Arch Pharmacol
November 2024
Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Ahram Canadian University, Giza, Egypt.
This research investigates the formulation of a nanogel complex using pectin and poly(acrylic acid) (PAAc) to encapsulate rutin. The nanogel's pH-responsive behavior and its potential as a targeted drug delivery platform are investigated. The gamma irradiation-induced crosslinking mechanism is elucidated, highlighting its role in creating a stable three-dimensional network structure within the polymer matrix.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!